Angela Chi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angela Chi has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Brad W. Neville
Distinguished University Professor, Division of Oral Pathology, Medical University of South Carolina, Charleston, SC
11 shared publications- Brad W. Neville
Medical University of South Carolina
11 shared publications Mary S. Richardson
Medical University of South Carolina
5 shared publicationsYi-Shing Lisa Cheng
Private Practice, Dallas, TX
3 shared publicationsDwight R. Weathers
2 shared publicationsHuey-Shys Chen
College of Medical and Health Care, HungKuang University, Taichung, Taiwan
2 shared publications
Latest Publications
- 26 October 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 108
Sialadenopapillary Ductal Tumor: Case Series and Review of the Literature
Purpose This study aims to characterize sialadenopapillary ductal tumors—a rare and recently described clinicopathologic spectrum of minor salivary gland neoplasms with prominent submucosal ductal proliferation. This spectrum includes lesions reported as sialadenoma papilliferum-like intraductal papillary tumor, tubulopapillary hidradenoma-like tumor of the mandible, papillary cystadenocarcinoma, and other entities. Methods Herein we report three additional cases of sialadenopapillary ductal tumor and review the English-language literature to identify previously reported cases with features of this tumor type. Inclusion criteria include the following: (1) neoplasm of likely minor salivary gland origin with prominent submucosal ductal proliferation, and (2) multiple bilayered to multilayered cystic structures with a peripheral myoepithelial cell layer. Excluded from our review were tumors with diagnostic features of intraductal carcinoma, salivary duct carcinoma, or epithelial-myoepithelial carcinoma (as per WHO criteria) as well as cases with inadequate documentation of histopathologic features. Results The current case series includes two patients with posterior mandibular tumors treated by marginal resection and one patient with a palatal tumor treated by simple excision. Review of the English-language literature reveals 37 previously reported cases with features of sialadenopapillary ductal tumor. Clinicopathologic findings for the current and previously reported cases include the following: mean age 64 years (range: 33–89 years), male-to-female ratio 1.5, most frequently involved sites: mandible and/or retromolar mandibular gingiva (n = 22) and palate (n = 11), mean tumor size 1.7 cm (range 0.2–4.2 cm), bone involvement (n = 21), surface involvement (n = 14), BRAF V600E immunohistochemistry positive (23 of 27 cases), surgical treatment ranging from curettage/excision/enucleation to resection, cervical lymph node metastasis (n = 1), recurrence (n = 3, ranging from 1 to 5 years after treatment). Conclusions Current data regarding this rare tumor type are limited to case series and individual case reports; our review of 40 documented cases in the existing literature and current series suggests that sialadenopapillary ductal tumors may represent low-grade adenocarcinomas amenable to surgical treatment and long-term surveillance. However, further studies are needed for improved characterization and development of evidence-based treatment guidelines. Awareness of this extremely rare entity is essential to ensure appropriate diagnosis.
- 26 October 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 108
Sialadenopapillary Ductal Tumor: Case Series and Review of the Literature
Purpose This study aims to characterize sialadenopapillary ductal tumors—a rare and recently described clinicopathologic spectrum of minor salivary gland neoplasms with prominent submucosal ductal proliferation. This spectrum includes lesions reported as sialadenoma papilliferum-like intraductal papillary tumor, tubulopapillary hidradenoma-like tumor of the mandible, papillary cystadenocarcinoma, and other entities. Methods Herein we report three additional cases of sialadenopapillary ductal tumor and review the English-language literature to identify previously reported cases with features of this tumor type. Inclusion criteria include the following: (1) neoplasm of likely minor salivary gland origin with prominent submucosal ductal proliferation, and (2) multiple bilayered to multilayered cystic structures with a peripheral myoepithelial cell layer. Excluded from our review were tumors with diagnostic features of intraductal carcinoma, salivary duct carcinoma, or epithelial-myoepithelial carcinoma (as per WHO criteria) as well as cases with inadequate documentation of histopathologic features. Results The current case series includes two patients with posterior mandibular tumors treated by marginal resection and one patient with a palatal tumor treated by simple excision. Review of the English-language literature reveals 37 previously reported cases with features of sialadenopapillary ductal tumor. Clinicopathologic findings for the current and previously reported cases include the following: mean age 64 years (range: 33–89 years), male-to-female ratio 1.5, most frequently involved sites: mandible and/or retromolar mandibular gingiva (n = 22) and palate (n = 11), mean tumor size 1.7 cm (range 0.2–4.2 cm), bone involvement (n = 21), surface involvement (n = 14), BRAF V600E immunohistochemistry positive (23 of 27 cases), surgical treatment ranging from curettage/excision/enucleation to resection, cervical lymph node metastasis (n = 1), recurrence (n = 3, ranging from 1 to 5 years after treatment). Conclusions Current data regarding this rare tumor type are limited to case series and individual case reports; our review of 40 documented cases in the existing literature and current series suggests that sialadenopapillary ductal tumors may represent low-grade adenocarcinomas amenable to surgical treatment and long-term surveillance. However, further studies are needed for improved characterization and development of evidence-based treatment guidelines. Awareness of this extremely rare entity is essential to ensure appropriate diagnosis.
- 11 January 2024
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 137 (6) , e131-e142
Calcified chondroid mesenchymal neoplasm: report of a case involving the temporomandibular joint region and review of the literature
- 11 January 2024
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 137 (6) , e131-e142
Calcified chondroid mesenchymal neoplasm: report of a case involving the temporomandibular joint region and review of the literature
- 31 March 2021
- Published by Springer Nature in Head and Neck Pathology
- Vol. 15 (3) , 935-944
Interobserver Variation in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma: Phase 2 Survey Study
In a previous study, we found interobserver agreement among 88 board-certified pathologists evaluating perineural invasion (PNI) in oral squamous cell carcinoma (OSCC) was fair, and participants most often used the following criteria: (1) tumor invading the perineurium, (2) tumor surrounding a nerve. In this study, we aimed to determine whether application of these most commonly used criteria may improve interobserver agreement. 512 pathologists were invited to participate in a web-based survey. Participants were asked to assess the presence/absence of PNI in a set of OSCC photomicrographs by applying each of the two criteria above. The survey was completed by 84 board-certified pathologists [mean age: 52 years (range 31–81), mean years in practice: 19 (range 1–56)]. Interobserver agreement was moderate (k = 0.46, 95% CI 0.45–0.46) when using definition #1 (tumor invading the perineurium) and fair (k = 0.24, 95% CI 0.23–0.25) when using definition #2 (tumor surrounding a nerve). By comparison, interobserver agreement was fair (k = 0.36, 95% CI 0.35–0.37) among phase 1 participants asked to evaluate these photomicrographs as they would in their pathology practice. Differences in kappa between definition #1 and phase 1, definition #2 and phase 2, and definition #1 and #2 were statistically significant (p < 0.001). Compared to our prior study based on pathologists’ personal views, the current study shows improved interobserver agreement with application of the criterion, “tumor invading the perineurium.” However, further work is needed to delineate concise, objective, and more reproducible criteria for histopathologic assessment of PNI.
- 31 March 2021
- Published by Springer Nature in Head and Neck Pathology
- Vol. 15 (3) , 935-944
Interobserver Variation in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma: Phase 2 Survey Study
In a previous study, we found interobserver agreement among 88 board-certified pathologists evaluating perineural invasion (PNI) in oral squamous cell carcinoma (OSCC) was fair, and participants most often used the following criteria: (1) tumor invading the perineurium, (2) tumor surrounding a nerve. In this study, we aimed to determine whether application of these most commonly used criteria may improve interobserver agreement. 512 pathologists were invited to participate in a web-based survey. Participants were asked to assess the presence/absence of PNI in a set of OSCC photomicrographs by applying each of the two criteria above. The survey was completed by 84 board-certified pathologists [mean age: 52 years (range 31–81), mean years in practice: 19 (range 1–56)]. Interobserver agreement was moderate (k = 0.46, 95% CI 0.45–0.46) when using definition #1 (tumor invading the perineurium) and fair (k = 0.24, 95% CI 0.23–0.25) when using definition #2 (tumor surrounding a nerve). By comparison, interobserver agreement was fair (k = 0.36, 95% CI 0.35–0.37) among phase 1 participants asked to evaluate these photomicrographs as they would in their pathology practice. Differences in kappa between definition #1 and phase 1, definition #2 and phase 2, and definition #1 and #2 were statistically significant (p < 0.001). Compared to our prior study based on pathologists’ personal views, the current study shows improved interobserver agreement with application of the criterion, “tumor invading the perineurium.” However, further work is needed to delineate concise, objective, and more reproducible criteria for histopathologic assessment of PNI.
- 8 April 2020
- Published by Springer Nature in Head and Neck Pathology
- Vol. 15 (1) , 288-297
Plexiform Schwannoma of the Oral Cavity: Report of Eight Cases and a Review of the Literature
Plexiform schwannoma represents an unusual schwannoma variant, characterized by multinodular growth grossly and/or microscopically. A review of the English-language literature reveals only 28 previously reported cases involving the oral cavity, and herein we present 8 additional cases. Among these 36 patients, the average age at diagnosis was 28 years (range 5 to 62 years), with a female-to-male ratio of 1.4:1. The most frequently involved sites were the tongue (n = 13) and lip (n = 11). Lesion duration prior to presentation averaged 5.3 years (range, 6 weeks to 26 years). The average lesion size was 2.1 cm (range, 0.3 to 16 cm). The typical clinical presentation was a painless mass, although infrequent findings included pain/discomfort, paresthesia, difficulty chewing, and limited buccal mobility. All cases clinically appeared as a solitary mass or localized cluster of tumor nodules, with the exception of one patient who had neurofibromatosis 2 (NF2) and exhibited two distinct nodules on the tongue and buccal mucosa. In addition, extraoral neural neoplasms were evident in four patients, including three with NF2. Typical microscopic findings included multiple well-circumscribed tumor nodules, each surrounded by a perineurium-derived capsule with immunoreactivity for epithelial membrane antigen. The nodules contained characteristically bland and diffusely S-100-positive spindle cells arranged in Antoni A and B patterns; however, modest nuclear pleomorphism was evident in three cases. Most patients (n = 23) were treated by excision or enucleation and curettage, and three patients experienced recurrence. Unlike plexiform neurofibromas, plexiform schwannomas exhibit only a weak association with neurofibromatosis and have no known malignant potential.
- 8 April 2020
- Published by Springer Nature in Head and Neck Pathology
- Vol. 15 (1) , 288-297
Plexiform Schwannoma of the Oral Cavity: Report of Eight Cases and a Review of the Literature
Plexiform schwannoma represents an unusual schwannoma variant, characterized by multinodular growth grossly and/or microscopically. A review of the English-language literature reveals only 28 previously reported cases involving the oral cavity, and herein we present 8 additional cases. Among these 36 patients, the average age at diagnosis was 28 years (range 5 to 62 years), with a female-to-male ratio of 1.4:1. The most frequently involved sites were the tongue (n = 13) and lip (n = 11). Lesion duration prior to presentation averaged 5.3 years (range, 6 weeks to 26 years). The average lesion size was 2.1 cm (range, 0.3 to 16 cm). The typical clinical presentation was a painless mass, although infrequent findings included pain/discomfort, paresthesia, difficulty chewing, and limited buccal mobility. All cases clinically appeared as a solitary mass or localized cluster of tumor nodules, with the exception of one patient who had neurofibromatosis 2 (NF2) and exhibited two distinct nodules on the tongue and buccal mucosa. In addition, extraoral neural neoplasms were evident in four patients, including three with NF2. Typical microscopic findings included multiple well-circumscribed tumor nodules, each surrounded by a perineurium-derived capsule with immunoreactivity for epithelial membrane antigen. The nodules contained characteristically bland and diffusely S-100-positive spindle cells arranged in Antoni A and B patterns; however, modest nuclear pleomorphism was evident in three cases. Most patients (n = 23) were treated by excision or enucleation and curettage, and three patients experienced recurrence. Unlike plexiform neurofibromas, plexiform schwannomas exhibit only a weak association with neurofibromatosis and have no known malignant potential.
- 16 October 2016
- Published by SAGE Publications in Trauma
- Vol. 20 (1) , 62-67
Electronic cigarette explosion: Case report of an emerging cause of orofacial trauma
Electronic cigarettes are a type of electronic nicotine delivery system. In the United States, electronic cigarettes have surged in popularity since their introduction to the market in 2007. Health and safety concerns primarily have focused on e-liquid/aerosol composition and whether these devices represent a gateway versus lower risk alternative to conventional cigarettes. Furthermore, recent incidents have demonstrated the potential for significant orofacial injury caused by device explosion while in use. Herein we report a case of a 20-year-old male who sustained oral burns, lacerations, and tooth loss when an electronic cigarette exploded in his mouth shortly after he charged the battery. Only seven other cases of trauma from intraoral electronic cigarette explosions have been reported in the scientific literature to date, although several similar incidents also have been reported by the news media. Treatment of such patients often requires a multidisciplinary approach. Design/manufacturing issues and improper handling may cause an increase in internal battery temperature. An investigation by the United States Fire Administration concluded that user education may aid in preventing some electronic cigarette explosions, and safety design improvements also could help. Although some studies and authorities support the use of electronic cigarettes for tobacco cessation and harm reduction, recent reports of electronic cigarette explosions raise important safety concerns and point to the need for further studies.
- 16 October 2016
- Published by SAGE Publications in Trauma
- Vol. 20 (1) , 62-67
Electronic cigarette explosion: Case report of an emerging cause of orofacial trauma
Electronic cigarettes are a type of electronic nicotine delivery system. In the United States, electronic cigarettes have surged in popularity since their introduction to the market in 2007. Health and safety concerns primarily have focused on e-liquid/aerosol composition and whether these devices represent a gateway versus lower risk alternative to conventional cigarettes. Furthermore, recent incidents have demonstrated the potential for significant orofacial injury caused by device explosion while in use. Herein we report a case of a 20-year-old male who sustained oral burns, lacerations, and tooth loss when an electronic cigarette exploded in his mouth shortly after he charged the battery. Only seven other cases of trauma from intraoral electronic cigarette explosions have been reported in the scientific literature to date, although several similar incidents also have been reported by the news media. Treatment of such patients often requires a multidisciplinary approach. Design/manufacturing issues and improper handling may cause an increase in internal battery temperature. An investigation by the United States Fire Administration concluded that user education may aid in preventing some electronic cigarette explosions, and safety design improvements also could help. Although some studies and authorities support the use of electronic cigarettes for tobacco cessation and harm reduction, recent reports of electronic cigarette explosions raise important safety concerns and point to the need for further studies.
- 4 May 2016
- Published by Springer Nature
- p. 282-285
Odontoma, Complex
- 4 May 2016
- Published by Springer Nature
- p. 222
Inner Enamel Epithelium
- 4 May 2016
- Published by Springer Nature
- p. 264-265
Odontogenic Carcinosarcoma
- 4 May 2016
- Published by Springer Nature
- p. 17-20
Ameloblastic Fibro-Odontoma